Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaPaul Nathan, Sophie Piperno‐Neumann, Marcus O. Butler et al.|New England Journal of Medicine|2021Cited by 869
Abstract 5295: Latent class longitudinal modeling of CTCs in ER+ metastatic breast cancer patientsTerry Hyslop, Massimo Cristofanilli, Xuechan Li et al.|Cancer Research|2015Cited by 0